MedTech Global Insights

This episode of MedTech Global Insights provides a deep dive into the General Safety and Performance Requirements (GSPR) of the EU MDR 2017/745, Annex I. We move beyond the checklist and explore the real-world challenges and regulatory expectations associated with these critical requirements. We uncover the most common pitfalls that can lead to Notified Body rejections, from inadequate justificati...

In this episode of MedTech Global Insights, we explore the Medical Device Single Audit Program (MDSAP), a revolutionary framework allowing MedTech and IVD manufacturers to satisfy the quality management system requirements of multiple countries through a single audit. We break down how this program can dramatically reduce audit fatigue and accelerate time-to-market. We detail the five core member...

As MedTech companies increasingly integrate artificial intelligence into Software as a Medical Device (SaMD), navigating the regulatory landscape becomes significantly more complex. The standard 510(k) pathway was not designed for adaptive algorithms, forcing the FDA and manufacturers to pioneer new approaches for ensuring safety and effectiveness throughout the product lifecycle. This episode del...

In this episode of MedTech Global Insights, we explore the new cornerstone of medical device security, the IEC 81001-5-1 standard. As healthcare technology becomes increasingly connected, the risk of cyber threats poses a significant danger to patient safety and can create major barriers to market entry. We break down what this standard means for manufacturers and why it's a critical component for...

SaMD developers operate in a fast-paced, agile world, but the medical device industry is governed by the structured ISO 13485 standard. This episode demystifies how to merge these two worlds, transforming compliance from a roadblock into an integrated part of your development lifecycle. We explore practical, real-world strategies to build a robust Quality Management System that satisfies regulator...

In this episode of MedTech Global Insights, we dissect the FDA's groundbreaking final guidance on Predetermined Change Control Plans (PCCPs) for AI/ML-enabled medical devices. We explore how this new framework moves beyond the traditional, rigid regulatory submission process, creating a streamlined pathway for manufacturers to innovate and improve their smart devices safely and effectively. Discov...

This episode of MedTech Global Insights delves into the rigorous clinical evaluation requirements for Software as a Medical Device (SaMD) under the European Union's Medical Device Regulation (MDR). We unpack the critical guidance from MDCG 2020-1, breaking down the three essential pillars of evidence required for your Clinical Evaluation Report: scientific validity, analytical validity, and clinic...

Getting a CE Mark for a traditional medical device is challenging enough, but the complexity multiplies when Artificial Intelligence is involved. This episode of MedTech Global Insights breaks down the intricate process of securing a CE Mark for AI-powered medical devices under the stringent EU Medical Device Regulation (MDR) and the new EU AI Act. Imagine developing a groundbreaking AI algorithm...

The rise of AI is revolutionizing medical technology, but it presents a unique challenge for regulators. How does the FDA approve a device that is designed to change and learn over time? This episode of MedTech Global Insights dives deep into the FDA's framework for AI-powered medical software, offering a clear guide for innovators. We break down the essentials of the premarket submission process,...

The global landscape for AI-enabled medical devices is rapidly evolving, with the two largest markets, the United States and the European Union, charting distinct regulatory courses. This episode of MedTech Global Insights provides a crucial breakdown of the fundamental differences between the FDA's iterative, change-oriented framework and the EU's comprehensive dual-system of the MDR and the new...

In this episode of MedTech Global Insights, we demystify the International Medical Device Regulators Forum (IMDRF) framework for Software as a Medical Device (SaMD). We break down the two-dimensional matrix used to classify SaMD risk, exploring how the significance of the information and the patient's condition determine whether your software is Class I or Class IV. We move beyond theory with conc...

Many MedTech and IVD companies rely on regulatory intelligence platforms like RegDesk for global expansion, only to discover that data alone doesn't get a product to market. This episode of MedTech Global Insights explores the critical gap between knowing the regulations and successfully executing a market submission. We break down the limitations of a platform-only approach and reveal what a trul...

Expanding into international markets is a critical growth driver for MedTech and IVD companies, but the path is often blocked by the high costs, slow pace, and fragmented nature of traditional, large-scale CROs. This episode explores the common pitfalls of the legacy model, where companies are forced to navigate siloed teams and redundant processes, leading to significant delays and budget overrun...

In this episode of MedTech Global Insights, we challenge the conventional wisdom of partnering with massive, one-size-fits-all CROs. While industry giants like ICON plc have their place, their pharma-centric models can stifle the agility and innovation that drive the MedTech sector. We explore the common frustrations of impersonal service, rigid processes, and spiraling costs that many device manu...

In the complex world of MedTech and IVD devices, selecting a regulatory partner is one of the most critical decisions for global growth. While large, established consulting firms like Pharmalex have long been the standard choice, many companies are now questioning if this model truly serves their needs. This episode explores the common challenges of working with industry giants, from communication...

The global MedTech regulatory landscape is notoriously complex. While established firms like Freyr Solutions have been a traditional choice, the industry is shifting towards more agile, technology-driven partners. This episode explores the limitations of legacy models and introduces a modern framework for achieving faster, more cost-effective global market access. We delve into the concept of a "s...

In this episode of MedTech Global Insights, we challenge the traditional, fragmented approach to regulatory consulting that often leaves MedTech and IVD companies struggling with delays, duplicated work, and inconsistent strategies across different markets. We explore the limitations of hiring multiple local consultants and introduce a modern, integrated alternative for achieving rapid and complia...

This episode of MedTech Global Insights challenges the one-size-fits-all approach to global regulatory compliance. We dive into the Medical Device Single Audit Program (MDSAP), exploring its benefits but also questioning whether it is the default best choice for every MedTech and IVD manufacturer seeking international growth. We uncover the powerful alternatives to MDSAP, focusing on a strategic,...

In this episode of MedTech Global Insights, we explore the critical role of the European Authorized Representative (EAR) and why the traditional, passive model is no longer sufficient for ambitious MedTech companies. We uncover the hidden costs and strategic disadvantages of using a simple "mailbox" service for EU compliance. We then introduce the modern alternative: the integrated global regulato...

In the world of MedTech, getting your device approved in one market is a milestone. But what happens when you aim for global scale? Many companies rely on traditional, single-market consultants, such as Registrar Corp for FDA approvals, only to find this approach creates bottlenecks when expanding further. This episode of MedTech Global Insights explores the hidden costs and inefficiencies of a fr...

In a MedTech consulting landscape dominated by large, traditional players like Emergo by UL, many companies are seeking more agile, efficient, and technologically advanced partners. This episode explores the evolution of global regulatory strategy, moving away from slow, siloed processes toward a modern, integrated approach. We uncover how combining a "Single Process, Multiple Markets" methodology...

In this episode of MedTech Global Insights, we explore the immense opportunities and critical challenges of entering Brazil's medical device market. We unpack the complex regulatory landscape governed by ANVISA and reveal the number one mistake foreign manufacturers make when seeking approval. Discover why your choice of a local partner can either lock your product's potential or unlock market-wid...

This episode of MedTech Global Insights delves into the strategic importance and regulatory complexities of the Singaporean medical device market. We explore the Health Sciences Authority (HSA) framework, from device classification and the Common Submission Dossier Template (CSDT) to the critical role of a local Singapore Registrant. Discover how to navigate these challenges effectively. We share...

Brazil's MedTech market offers immense growth opportunities, but entry is guarded by the complex dual-gatekeeper system of ANVISA and INMETRO. This episode of MedTech Global Insights demystifies this process, revealing the common and costly pitfalls that international manufacturers face when seeking certification and registration for their medical devices. We move beyond theory to discuss what def...

In this episode of MedTech Global Insights, we dissect a crucial, yet often overlooked, aspect of entering one of Asia's premier MedTech hubs: Singapore. We explore the intricacies of the Health Sciences Authority's (HSA) Good Distribution Practice for Medical Devices (GDPMDS), a mandatory certification that governs the entire supply chain. We move beyond the theory to discuss why even companies w...